Clinical Presentation of a Complex Neurodevelopmental Disorder Caused by Mutations in ADNP
Ver/ Abrir
Registro completo
Mostrar el registro completo DCAutoría
Van Dijck, Anke; Vulto-van Silfhout, Anneke T.; Cappuyns, Elisa; van der Werf, Ilse M.; Mancini, Grazia M.; Tzschach, Andreas; Bernier, Raphael; Gozes, Illana; Eichler, Evan E.; Romano, Corrado; Lindstrand, Anna; Nordgren, Ann; ADNP Consortium; González-Lamuño Leguina, Domingo
Fecha
2019-02Derechos
© 2019. This manuscript version is made available under the CC-BY-NC-ND 4.0 license
Publicado en
Biological Psychiatry
Volume 85, Issue 4, 15 February 2019, Pages 287-297
Editorial
Elsevier
Enlace a la publicación
Palabras clave
ADNP
Autism
Genetics
Helsmoortel-Van der Aa Síndrome
Intellectual Disability
Neurodevelopmental Disorder
Resumen/Abstract
Background
In genome-wide screening studies for de novo mutations underlying autism and intellectual disability, mutations in the ADNP gene are consistently reported among the most frequent. ADNP mutations have been identified in children with autism spectrum disorder comorbid with intellectual disability, distinctive facial features, and deficits in multiple organ systems. However, a comprehensive clinical description of the Helsmoortel-Van der Aa syndrome is lacking.
Methods
We identified a worldwide cohort of 78 individuals with likely disruptive mutations in ADNP from January 2014 to October 2016 through systematic literature search, by contacting collaborators, and through direct interaction with parents. Clinicians filled in a structured questionnaire on genetic and clinical findings to enable correlations between genotype and phenotype. Clinical photographs and specialist reports were gathered. Parents were interviewed to complement the written questionnaires.
Results
We report on the detailed clinical characterization of a large cohort of individuals with an ADNP mutation and demonstrate a distinctive combination of clinical features, including mild to severe intellectual disability, autism, severe speech and motor delay, and common facial characteristics. Brain abnormalities, behavioral problems, sleep disturbance, epilepsy, hypotonia, visual problems, congenital heart defects, gastrointestinal problems, short stature, and hormonal deficiencies are common comorbidities. Strikingly, individuals with the recurrent p.Tyr719* mutation were more severely affected.
Conclusions
This overview defines the full clinical spectrum of individuals with ADNP mutations, a specific autism subtype. We show that individuals with mutations in ADNP have many overlapping clinical features that are distinctive from those of other autism and/or intellectual disability syndromes. In addition, our data show preliminary evidence of a correlation between genotype and phenotype.
Colecciones a las que pertenece
- D06 Artículos [576]